RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4

Molecular Oncology

Volumn 10, Issue 8, 2016, Pages 1169-1182

  Kirby, Marie K ^a   Ramaker, Ryne C ^a,b   Gertz, Jason ^a,d   Davis, Nicholas S ^a   Johnston, Bobbi E ^a   Oliver, Patsy G ^b   Sexton, Katherine C ^b   Greeno, Edward W ^c   Christein, John D ^b   Heslin, Martin J ^b   Posey, James A ^b   Grizzle, William E ^b   Vickers, Selwyn M ^b   Buchsbaum, Donald J ^b   Cooper, Sara J ^a   Myers, Richard M ^a  

^a HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

ANGPTL4; Gemcitabine; Pancreatic adenocarcinoma; RNA seq

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE 4; GEMCITABINE; RNA; UNCLASSIFIED DRUG; ANGPTL4 PROTEIN, HUMAN; DEOXYCYTIDINE; MESSENGER RNA;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CELL DIVISION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREATIC CANCER CELL LINE; PRIORITY JOURNAL; RNA SEQUENCE; SURVIVAL TIME; ADENOCARCINOMA; AGED; ANALOGS AND DERIVATIVES; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PANCREATIC NEOPLASMS; PATHOLOGY; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; SEQUENCE ANALYSIS; SURVIVAL ANALYSIS; TIME FACTOR;

ADENOCARCINOMA; AGED; ANGIOPOIETINS; CELL PROLIFERATION; DEOXYCYTIDINE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RNA, MESSENGER; ROC CURVE; SEQUENCE ANALYSIS, RNA; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 84992740842     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2016.05.004     Document Type: Article

References (61)

1. Akisawa, N., Nishimori, I., Iwamura, T., Onishi, S., Hollingsworth, M.A., High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential. Biochem. Biophys. Res. Commun. 258 (1999), 395–400, 10.1006/bbrc.1999.0653.
2. Bailey, P., Chang, D.K., Nones, K., Johns, A.L., Patch, A.-M., Gingras, M.-C., Miller, D.K., Christ, A.N., Bruxner, T.J.C., Quinn, M.C., Nourse, C., Murtaugh, L.C., Harliwong, I., Idrisoglu, S., Manning, S., Nourbakhsh, E., Wani, S., Fink, L., Holmes, O., Chin, V., Anderson, M.J., Kazakoff, S., Leonard, C., Newell, F., Waddell, N., Wood, S., Xu, Q., Wilson, P.J., Cloonan, N., Kassahn, K.S., Taylor, D., Quek, K., Robertson, A., Pantano, L., Mincarelli, L., Sanchez, L.N., Evers, L., Wu, J., Pinese, M., Cowley, M.J., Jones, M.D., Colvin, E.K., Nagrial, A.M., Humphrey, E.S., Chantrill, L.A., Mawson, A., Humphris, J., Chou, A., Pajic, M., Scarlett, C.J., Pinho, A.V., Giry-Laterriere, M., Rooman, I., Samra, J.S., Kench, J.G., Lovell, J.A., Merrett, N.D., Toon, C.W., Epari, K., Nguyen, N.Q., Barbour, A., Zeps, N., Moran-Jones, K., Jamieson, N.B., Graham, J.S., Duthie, F., Oien, K., Hair, J., Grützmann, R., Maitra, A., Iacobuzio-Donahue, C.A., Wolfgang, C.L., Morgan, R.A., Lawlor, R.T., Corbo, V., Bassi, C., Rusev, B., Capelli, P., Salvia, R., Tortora, G., Mukhopadhyay, D., Petersen, G.M., Initiative, A.P.C.G., Munzy, D.M., Fisher, W.E., Karim, S.A., Eshleman, J.R., Hruban, R.H., Pilarsky, C., Morton, J.P., Sansom, O.J., Scarpa, A., Musgrove, E.A., Bailey, U.-M.H., Hofmann, O., Sutherland, R.L., Wheeler, D.A., Gill, A.J., Gibbs, R.A., Pearson, J.V., Waddell, N., Biankin, A.V., Grimmond, S.M., Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531 (2016), 47–52.
3. Biankin, A.V., Waddell, N., Kassahn, K.S., Gingras, M.-C., Muthuswamy, L.B., Johns, A.L., Miller, D.K., Wilson, P.J., Patch, A.-M., Wu, J., Chang, D.K., Cowley, M.J., Gardiner, B.B., Song, S., Harliwong, I., Idrisoglu, S., Nourse, C., Nourbakhsh, E., Manning, S., Wani, S., Gongora, M., Pajic, M., Scarlett, C.J., Gill, A.J., Pinho, A.V., Rooman, I., Anderson, M., Holmes, O., Leonard, C., Taylor, D., Wood, S., Xu, Q., Nones, K., Fink, J.L., Christ, A., Bruxner, T., Cloonan, N., Kolle, G., Newell, F., Pinese, M., Mead, R.S., Humphris, J.L., Kaplan, W., Jones, M.D., Colvin, E.K., Nagrial, A.M., Humphrey, E.S., Chou, A., Chin, V.T., Chantrill, L.A., Mawson, A., Samra, J.S., Kench, J.G., Lovell, J.A., Daly, R.J., Merrett, N.D., Toon, C., Epari, K., Nguyen, N.Q., Barbour, A., Zeps, N., Initiative, A.P.C.G., Kakkar, N., Zhao, F., Wu, Y.Q., Wang, M., Muzny, D.M., Fisher, W.E., Brunicardi, F.C., Hodges, S.E., Reid, J.G., Drummond, J., Chang, K., Han, Y., Lewis, L.R., Dinh, H., Buhay, C.J., Beck, T., Timms, L., Sam, M., Begley, K., Brown, A., Pai, D., Panchal, A., Buchner, N., De Borja, R., Denroche, R.E., Yung, C.K., Serra, S., Onetto, N., Mukhopadhyay, D., Tsao, M.-S., Shaw, P.A., Petersen, G.M., Gallinger, S., Hruban, R.H., Maitra, A., Iacobuzio-Donahue, C.A., Schulick, R.D., Wolfgang, C.L., Morgan, R.A., Lawlor, R.T., Capelli, P., Corbo, V., Scardoni, M., Tortora, G., Tempero, M.A., Mann, K.M., Jenkins, N.A., Perez-Mancera, P.A., Adams, D.J., Largaespada, D.A., Wessels, L.F.A., Rust, A.G., Stein, L.D., Tuveson, D.A., Copeland, N.G., Musgrove, E.A., Scarpa, A., Eshleman, J.R., Hudson, T.J., Sutherland, R.L., Wheeler, D.A., Pearson, J.V., McPherson, J.D., Gibbs, R.A., Grimmond, S.M., Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491 (2012), 399–405, 10.1038/nature11547.
4. Bruns, C.J., Harbison, M.T., Kuniyasu, H., Eue, I., Fidler, I.J., In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice. Neoplasia 1 (1999), 50–62.
5. Collisson, E.A., Sadanandam, A., Olson, P., Gibb, W.J., Truitt, M., Gu, S., Cooc, J., Weinkle, J., Kim, G.E., Jakkula, L., Feiler, H.S., Ko, A.H., Olshen, A.B., Danenberg, K.L., Tempero, M.A., Spellman, P.T., Hanahan, D., Gray, J.W., Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat. Med. 17 (2011), 500–503, 10.1038/nm.2344.
6. Conroy, T., Desseigne, F., Ychou, M., Bouche, O., Guimbaud, R., Becouarn, Y., Adenis, A., Raoul, J.L., Gourgou-Bourgade, S., de la Fouchardiere, C., Bennouna, J., Bachet, J.B., Khemissa-Akouz, F., Pere-Verge, D., Delbaldo, C., Assenat, E., Chauffert, B., Michel, P., Montoto-Grillot, C., Ducreux, M., FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N. Engl. J. Med. 364 (2011), 1817–1825, 10.1056/NEJMoa1011923.
7. da Huang, W., Sherman, B.T., Lempicki, R.A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc., 4, 2009, 10.1038/nprot.2008.211.
8. Donahue, T.R., Tran, L.M., Hill, R., Li, Y., Kovochich, A., Calvopina, J.H., Patel, S.G., Wu, N., Hindoyan, A., Farrell, J.J., Li, X., Dawson, D.W., Wu, H., Integrative survival-based molecular profiling of human pancreatic cancer. Clin. Cancer Res. 18 (2012), 1352–1363, 10.1158/1078-0432.CCR-11-1539.
9. Friedman, J., Hastie, T., Tibshirani, R., Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33 (2010), 1–22.
10. Ge, X., Yamamoto, S., Tsutsumi, S., Midorikawa, Y., Ihara, S., Wang, S.M., Aburatani, H., Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 86 (2005), 127–141.
11. Gertz, J., Varley, K.E., Davis, N.S., Baas, B.J., Goryshin, I.Y., Vaidyanathan, R., Kuersten, S., Myers, R.M., Transposase mediated construction of RNA-seq libraries. Genome Res. 22 (2012), 134–141, 10.1101/gr.127373.111.
12. Gocheva, V., Chen, X., Peters, C., Reinheckel, T., Joyce, J.A., Deletion of cathepsin H perturbs angiogenic switching, vascularization and growth of tumors in a mouse model of pancreatic islet cell cancer. Biol. Chem. 391 (2010), 937–945, 10.1515/BC.2010.080.
13. Griffith, O.L., Pepin, F., Enache, O.M., Heiser, L.M., Collisson, E.A., Spellman, P.T., Gray, J.W., A robust prognostic signature for hormone-positive node-negative breast cancer. Genome Med. 5 (2013), 1–14, 10.1186/gm496.
14. Halestrap, A.P., The SLC16 gene family – structure, role and regulation in health and disease. Mol. Aspects Med. 34 (2013), 337–349.
15. Hanoun, N., Bureau, C., Diab, T., Gayet, O., Dusetti, N., Selves, J., Vinel, J.-P., Buscail, L., Cordelier, P., Torrisani, J., The SV2 variant of KLF6 is down-regulated in hepatocellular carcinoma and displays anti-proliferative and pro-apoptotic functions. J. Hepatol. 53 (2015), 880–888, 10.1016/j.jhep.2010.04.038.
16. Harrell, F., Regression Modeling Strategies with Applications to Linear Models, Logistic Regression, and Survival Analysis. 2001, Springer-Verlag, New York.
17. Harrow, J., Denoeud, F., Frankish, A., Reymond, A., Chen, C.-K., Chrast, J., Lagarde, J., Gilbert, J.G.R., Storey, R., Swarbreck, D., Rossier, C., Ucla, C., Hubbard, T., Antonarakis, S.E., Guigo, R., GENCODE: producing a reference annotation for ENCODE. Genome Biol. 7:Suppl. 1 (2006), S4.1–S4.9.
18. Hartel, M., Narla, G., Wente, M.N., Giese, N.A., Martignoni, M.E., Martignetti, J.A., Friess, H., Friedman, S.L., Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer. Eur. J. Cancer 44 (2008), 1895–1903.
19. Heinemann, V., Boeck, S., Perioperative management of pancreatic cancer. Ann. Oncol. 19 (2008), 273–278, 10.1093/annonc/mdn450.
20. Hu, Z., Fan, C., Livasy, C., He, X., Oh, D.S., Ewend, M.G., Carey, L.A., Subramanian, S., West, R., Ikpatt, F., Olopade, O.I., van de Rijn, M., Perou, C.M., A compact VEGF signature associated with distant metastases and poor outcomes. BMC Med., 7, 2009, 9.
21. Huntzinger, E., Braun, J.E., Heimstädt, S., Zekri, L., Izaurralde, E., Two PABPC1-binding sites in GW182 proteins promote miRNA-mediated gene silencing. EMBO J. 29 (2010), 4146–4160.
22. Isserlin, R., Merico, D., Voisin, V., Bader, G.D., Enrichment Map – a Cytoscape app to visualize and explore OMICs pathway enrichment results. F1000Research, 3, 2014, 141, 10.12688/f1000research.4536.1.
23. Iwamura, T., Caffrey, T.C., Kitamura, N., Yamanari, H., Setoguchi, T., Hollingsworth, M.A., P-selectin expression in a metastatic pancreatic tumor cell line (SUIT-2). Cancer Res. 57 (1997), 1206–1212.
24. Jaffee, E.M., Schutte, M., Gossett, J., Morsberger, L.A., Adler, A.J., Thomas, M., Greten, T.F., Hruban, R.H., Yeo, C.J., Griffin, C.A., Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials. Cancer J. Sci. Am. 4 (1998), 194–203.
25. Jinek, M., Fabian, M.R., Coyle, S.M., Sonenberg, N., Doudna, J.A., Structural insights into the human GW182-PABC interaction in microRNA-mediated deadenylation. Nat. Struct. Mol. Biol. 17 (2010), 238–240.
26. Johnson, R.H., Hu, P., Fan, C., Anders, C.K., Gene expression in “young adult type” breast cancer: a retrospective analysis. Oncotarget 6 (2015), 13688–13702.
27. Jones, S., Zhang, X., Parsons, D.W., Lin, J.C.-H., Leary, R.J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., Hong, S.-M., Fu, B., Lin, M.-T., Calhoun, E.S., Kamiyama, M., Walter, K., Nikolskaya, T., Nikolsky, Y., Hartigan, J., Smith, D.R., Hidalgo, M., Leach, S.D., Klein, A.P., Jaffee, E.M., Goggins, M., Maitra, A., Iacobuzio-Donahue, C., Eshleman, J.R., Kern, S.E., Hruban, R.H., Karchin, R., Papadopoulos, N., Parmigiani, G., Vogelstein, B., Velculescu, V.E., Kinzler, K.W., Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321 (2008), 1801–1806, 10.1126/science.1164368.
28. Kalser, M.H., Ellenberg, S.S., Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch. Surg. 120 (1985), 899–903.
29. Kanwar, N., Hu, P., Bedard, P., Clemons, M., McCready, D., Done, S.J., Identification of genomic signatures in circulating tumor cells from breast cancer. Int. J. Cancer 137 (2015), 332–344, 10.1002/ijc.29399.
30. Kim, J.H., Karnovsky, A., Mahavisno, V., Weymouth, T., Pande, M., Dolinoy, D.C., Rozek, L.S., Sartor, M.A., LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types. BMC Genomics, 13, 2012, 526, 10.1186/1471-2164-13-526.
31. Kutner, R.H., Zhang, X.-Y., Reiser, J., Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat. Protoc. 4 (2009), 495–505.
32. Langfelder, P., Horvath, S., WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9 (2008), 1–13, 10.1186/1471-2105-9-559.
33. Love, M.I., Huber, W., Anders, S., Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. BioRxiv, 2014, 1–21, 10.1101/002832.
34. Madar, S., Brosh, R., Buganim, Y., Ezra, O., Goldstein, I., Solomon, H., Kogan, I., Goldfinger, N., Klocker, H., Rotter, V., Modulated expression of WFDC1 during carcinogenesis and cellular senescence. Carcinogenesis 30 (2009), 20–27, 10.1093/carcin/bgn232.
35. McEvoy, L.M., O'Toole, S.A., Spillane, C.D., Martin, C.M., Gallagher, M.F., Stordal, B., Blackshields, G., Sheils, O., O'Leary, J.J., Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer. BMC Cancer, 15, 2015, 547, 10.1186/s12885-015-1539-8.
36. Newhook, T.E., Blais, E.M., Lindberg, J.M., Adair, S.J., Xin, W., Lee, J.K., Papin, J.A., Parsons, J.T., Bauer, T.W., A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest. PLoS One, 9, 2014, e105631, 10.1371/journal.pone.0105631.
37. Ng, K.T.-P., Xu, A., Cheng, Q., Guo, D.Y., Lim, Z.X.-H., Sun, C.K.-W., Fung, J.H.-S., Poon, R.T.-P., Fan, S.T., Lo, C.M., Man, K., Clinical relevance and therapeutic potential of angiopoietin-like protein 4 in hepatocellular carcinoma. Mol. Cancer, 13, 2014, 196, 10.1186/1476-4598-13-196.
38. Oettle, H., Neuhaus, P., Hochhaus, A., et al. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the conko-001 randomized trial. JAMA 310 (2013), 1473–1481.
39. Orr, B., Grace, O.C., Brown, P., Riddick, A.C.P., Stewart, G.D., Franco, O.E., Hayward, S.W., Thomson, A.A., Reduction of pro-tumorigenic activity of human prostate cancer-associated fibroblasts using Dlk1 or SCUBE1. Dis. Model. Mech. 6 (2013), 530–536, 10.1242/dmm.010355.
40. Paniccia, A., Hosokawa, P., Henderson, W., Al, E., Characteristics of 10-year survivors of pancreatic ductal adenocarcinoma. JAMA Surg. 150 (2015), 701–710, 10.1001/jamasurg.2015.0668.
41. Pérez-Mancera, P.A., Rust, A.G., van der Weyden, L., Kristiansen, G., Li, A., Sarver, A.L., Silverstein, K.A.T., Grützmann, R., Aust, D., Rümmele, P., Knösel, T., Herd, C., Stemple, D.L., Kettleborough, R., Brosnan, J.A., Li, A., Morgan, R., Knight, S., Yu, J., Stegeman, S., Collier, L.S., ten Hoeve, J.J., de Ridder, J., Klein, A.P., Goggins, M., Hruban, R.H., Chang, D.K., Biankin, A.V., Grimmond, S.M., APGI, Wessels, L.F.A., Wood, S.A., Iacobuzio-Donahue, C.A., Pilarsky, C., Largaespada, D.A., Adams, D.J., Tuveson, D.A., The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature 486 (2012), 266–270, 10.1038/nature11114.
42. Potapenko, I.O., Lüders, T., Russnes, H.G., Helland, Å., Sørlie, T., Kristensen, V.N., Nord, S., Lingjærde, O.C., Børresen-Dale, A.-L., Haakensen, V.D., Glycan-related gene expression signatures in breast cancer subtypes; relation to survival. Mol. Oncol. 9 (2015), 861–876, 10.1016/j.molonc.2014.12.013.
43. Quinlan, A.R., BEDTools: the Swiss-army tool for genome feature analysis. Current Protocols in Bioinformatics, 2002, John Wiley & Sons, Inc, 10.1002/0471250953.bi1112s47.
44. Riker, A.I., Enkemann, S.A., Fodstad, O., Liu, S., Ren, S., Morris, C., Xi, Y., Howell, P., Metge, B., Samant, R.S., Shevde, L.A., Li, W., Eschrich, S., Daud, A., Ju, J., Matta, J., The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med. Genomics, 1, 2008, 13.
45. Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2015. CA Cancer J. Clin. 65 (2015), 5–29, 10.3322/caac.21254.
46. Simon, N., Friedman, J., Hastie, T., Tibshirani, R., Regularization paths for cox's proportional hazards model via coordinate descent. J. Stat. Softw. 39 (2011), 1–13.
47. Sing, T., Sander, O., Beerenwinkel, N., Lengauer, T., ROCR: visualizing classifier performance in R. Bioinformatics 21 (2005), 3940–3941, 10.1093/bioinformatics/bti623.
48. Stathis, A., Moore, M.J., Advanced pancreatic carcinoma: current treatment and future challenges. Nat. Rev. Clin. Oncol. 7 (2010), 163–172, 10.1038/nrclinonc.2009.236.
49. Stratford, J.K., Bentrem, D.J., Anderson, J.M., Fan, C., Volmar, K.A., Marron, J.S., Routh, E.D., Caskey, L.S., Samuel, J.C., Der, C.J., Thorne, L.B., Calvo, B.F., Kim, H.J., Talamonti, M.S., Iacobuzio-Donahue, C.A., Hollingsworth, M.A., Perou, C.M., Yeh, J.J., A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma. PLoS Med., 7, 2010, 10.1371/journal.pmed.1000307.
50. Suzuki, A., Horiuchi, A., Ashida, T., Miyamoto, T., Kashima, H., Nikaido, T., Konishi, I., Shiozawa, T., Cyclin A2 confers cisplatin resistance to endometrial carcinoma cells via up-regulation of an Akt-binding protein, periplakin. J. Cell. Mol. Med. 14 (2010), 2305–2317, 10.1111/j.1582-4934.2009.00839.x.
51. Tan, M.J., Teo, Z., Sng, M.K., Zhu, P., Tan, N.S., Emerging roles of angiopoietin-like 4 in human cancer. Mol. Cancer Res. 10 (2012), 677–688, 10.1158/1541-7786.MCR-11-0519.
52. Tanaka, M., Shimbo, T., Kikuchi, Y., Matsuda, M., Kaneda, Y., Sterile alpha motif containing domain 9 is involved in death signaling of malignant glioma treated with inactivated Sendai virus particle (HVJ-E) or type I interferon. Int. J. Cancer 126 (2010), 1982–1991, 10.1002/ijc.24965.
53. Tibshirani, R., Regression shrinkage and selection via the lasso. J. R. Stat. Soc. B 58 (1996), 267–288.
54. Trapnell, C., Pachter, L., Salzberg, S.L., TopHat: discovering splice junctions with RNA-seq. Bioinformatics 25 (2009), 1105–1111, 10.1093/bioinformatics/btp120.
55. Trapnell, C., Williams, B.A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M.J., Salzberg, S.L., Wold, B.J., Pachter, L., Transcript assembly and quantification by RNA-seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28 (2010), 511–515, 10.1038/nbt.1621.
56. Venet, D., Dumont, J.E., Detours, V., Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Comput. Biol., 7, 2011, 10.1371/journal.pcbi.1002240.
57. Von Hoff, D.D., Ramanathan, R.K., Borad, M.J., Laheru, D.A., Smith, L.S., Wood, T.E., Korn, R.L., Desai, N., Trieu, V., Iglesias, J.L., Zhang, H., Soon-Shiong, P., Shi, T., Rajeshkumar, N.V., Maitra, A., Hidalgo, M., Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. J. Clin. Oncol. 29 (2011), 4548–4554, 10.1200/JCO.2011.36.5742.
58. Waddell, N., Pajic, M., Patch, A.-M., Chang, D.K., Kassahn, K.S., Bailey, P., Johns, A.L., Miller, D., Nones, K., Quek, K., Quinn, M.C.J., Robertson, A.J., Fadlullah, M.Z.H., Bruxner, T.J.C., Christ, A.N., Harliwong, I., Idrisoglu, S., Manning, S., Nourse, C., Nourbakhsh, E., Wani, S., Wilson, P.J., Markham, E., Cloonan, N., Anderson, M.J., Fink, J.L., Holmes, O., Kazakoff, S.H., Leonard, C., Newell, F., Poudel, B., Song, S., Taylor, D., Waddell, N., Wood, S., Xu, Q., Wu, J., Pinese, M., Cowley, M.J., Lee, H.C., Jones, M.D., Nagrial, A.M., Humphris, J., Chantrill, L.A., Chin, V., Steinmann, A.M., Mawson, A., Humphrey, E.S., Colvin, E.K., Chou, A., Scarlett, C.J., Pinho, A.V., Giry-Laterriere, M., Rooman, I., Samra, J.S., Kench, J.G., Pettitt, J.A., Merrett, N.D., Toon, C., Epari, K., Nguyen, N.Q., Barbour, A., Zeps, N., Jamieson, N.B., Graham, J.S., Niclou, S.P., Bjerkvig, R., Grützmann, R., Aust, D., Hruban, R.H., Maitra, A., Iacobuzio-Donahue, C.A., Wolfgang, C.L., Morgan, R.A., Lawlor, R.T., Corbo, V., Bassi, C., Falconi, M., Zamboni, G., Tortora, G., Tempero, M.A., Initiative, A.P.C.G., Gill, A.J., Eshleman, J.R., Pilarsky, C., Scarpa, A., Musgrove, E.A., Pearson, J.V., Biankin, A.V., Grimmond, S.M., Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518 (2015), 495–501, 10.1038/nature14169.
59. Wu, T.T., Gong, H., Clarke, E.M., A transcriptome analysis by lasso penalized cox regression for pancreatic cancer survival. J. Bioinform. Comput. Biol. 9 (2011), 63–73.
60. Zeileis, A., Hothron, T., Diagnostic checking in regression relationships. R News 2 (2002), 7–10.
61. Zhang, J., Baran, J., Cros, A., Guberman, J.M., Haider, S., Hsu, J., Liang, Y., Rivkin, E., Wang, J., Whitty, B., Wong-Erasmus, M., Yao, L., Kasprzyk, A., International Cancer Genome Consortium Data Portal—a one-stop shop for cancer genomics data. Database, 2011, 2011, 10.1093/database/bar026 bar026.